D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$520M |
| 2 |
Accenture
ACN
|
+$474M |
| 3 |
Intel
INTC
|
+$436M |
| 4 |
Adobe
ADBE
|
+$318M |
| 5 |
Northrop Grumman
NOC
|
+$262M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.23B |
| 2 |
Apple
AAPL
|
+$900M |
| 3 |
Microsoft
MSFT
|
+$733M |
| 4 |
Netflix
NFLX
|
+$637M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.68% |
| 2 | Consumer Discretionary | 10.14% |
| 3 | Financials | 7.13% |
| 4 | Healthcare | 6.41% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Molson Coors Class B
TAP
$8.14B
| $32.6M | 0.03% |
642,048
+8,348
| +1% | +$483K |
|
|
BPMC
577
DELISTED
Blueprint Medicines
BPMC
| $32.6M | 0.03% |
302,635
-73,542
| -20% | -$7.36M |
|
578
Zeta Global
ZETA
$5.61B
| $32.6M | 0.03% |
1,847,610
+1,728,005
| +1,445% | +$25.3M |
|
579
CALL
AutoZone
AZO
$51.2B
| $32.6M | 0.03% |
11,000
-40,100
| -78% | -$117M |
|
580
Liberty Live Group Series A
LLYVA
$9.14B
| $32.6M | 0.03% |
868,590
+43,399
| +5% | +$1.62M |
|
581
Fox Factory Holding Corp
FOXF
$806M
| $32.5M | 0.03% |
674,051
+135,542
| +25% | +$6.13M |
|
582
Zoom
ZM
$26.9B
| $32.5M | 0.03% |
548,731
-1,738,492
| -76% | -$107M |
|
583
National Vision
EYE
$1.73B
| $32.5M | 0.03% |
2,479,245
+1,330,023
| +116% | +$21.8M |
|
584
CALL
American Airlines Group
AAL
$9.99B
| $32.4M | 0.03% |
2,858,600
+775,900
| +37% | +$10.2M |
|
585
CALL
ConocoPhillips
COP
$144B
| $32.3M | 0.03% |
282,700
-121,600
| -30% | -$14.8M |
|
586
Warner Music
WMG
$15.4B
| $32.2M | 0.03% |
1,050,210
+497,102
| +90% | +$16M |
|
587
Power Integrations
POWI
$3.27B
| $32.1M | 0.03% |
457,470
+131,735
| +40% | +$9.46M |
|
588
CALL
C3.ai
AI
$1.39B
| $32M | 0.03% |
1,103,800
+123,800
| +13% | +$3.18M |
|
589
CALL
CVS Health
CVS
$138B
| $31.9M | 0.03% |
539,400
-499,200
| -48% | -$31.2M |
|
590
Transmedics
TMDX
$2.64B
| $31.7M | 0.03% |
+210,271
| New | +$25.2M |
|
591
Citizens Financial Group
CFG
$30.5B
| $31.7M | 0.03% |
878,888
+420,404
| +92% | +$14.7M |
|
592
PUT
Alcoa
AA
$11.5B
| $31.5M | 0.03% |
791,700
-952,500
| -55% | -$36.9M |
|
593
Cooper Companies
COO
$14.2B
| $31.4M | 0.03% |
360,018
+167,061
| +87% | +$15.6M |
|
594
Celldex Therapeutics
CLDX
$2.82B
| $31.3M | 0.03% |
845,560
+272,389
| +48% | +$10.3M |
|
|
SILK
595
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $31.2M | 0.03% |
1,154,781
-444,710
| -28% | -$9.25M |
|
596
CALL
W.W. Grainger
GWW
$64.8B
| $31.1M | 0.03% |
34,500
-35,000
| -50% | -$32.9M |
|
597
Coca-Cola
KO
$389B
| $31.1M | 0.03% |
488,724
-794,499
| -62% | -$49.2M |
|
598
PROG Holdings
PRG
$1.66B
| $31.1M | 0.03% |
896,075
+6,803
| +0.8% | +$235K |
|
599
IDEAYA Biosciences
IDYA
$3.47B
| $31.1M | 0.03% |
884,538
+226,514
| +34% | +$8.97M |
|
600
Lam Research
LRCX
$329B
| $31M | 0.03% |
291,230
+150,790
| +107% | +$14.5M |
|
Similar funds
D.E. Shaw & Co's Q2 2024 Portfolio in Review
As of Q2 2024, D.E. Shaw & Co held 4,975 positions worth $107B, down 8.5% from $117B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $20B in Q2 2024, closing 541 positions and reducing 1,567 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $542M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in iShares JPMorgan USD Emerging Markets Bond ETF worth $258M.
- D.E. Shaw & Co's largest Q2 2024 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 2,917,600 shares worth $258M.
- D.E. Shaw & Co added most to Broadcom in Q2 2024, an estimated $520M increase.
- D.E. Shaw & Co's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $1.23B.
- D.E. Shaw & Co fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $542M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $107B portfolio in Q2 2024.
- D.E. Shaw & Co opened 693 new positions and closed 541 in Q2 2024.
- D.E. Shaw & Co's portfolio value fell 8.5% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.